Positron Corp (POSC) stock
POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.70+0.15 (+9.68%)
Close on Oct 19, 2026Market cap $55.84MP/E –Yield –
Positron r&d expenses
Research and development expenses are spending on new products and technology.
Positron's R&D Expenses for the twelve months ending Sep 30, 2015 was $250.00K, down 43.7% year over year. For fiscal 2014 it was $471.00K, down 16.5% from the year before. The highest annual figure on record is $1.32M in fiscal 2011.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $471.00K | -16.5% |
| FY2013 | Dec 31, 2013 | $564.00K | -40.0% |
| FY2012 | Dec 31, 2012 | $940.00K | -28.5% |
| FY2011 | Dec 31, 2011 | $1.32M | +3.1% |
| FY2010 | Dec 31, 2010 | $1.28M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2015 | Sep 30, 2015 | $2.00K | -98.4% |
| Q2 FY2015 | Jun 30, 2015 | $5.00K | -95.8% |
| Q1 FY2015 | Mar 31, 2015 | $120.00K | +17.6% |
| Q4 FY2014 | Dec 31, 2014 | $123.00K | +28.1% |
| Q3 FY2014 | Sep 30, 2014 | $126.00K | -5.3% |
| Q2 FY2014 | Jun 30, 2014 | $120.00K | +12.1% |
| Q1 FY2014 | Mar 31, 2014 | $102.00K | -55.3% |
| Q4 FY2013 | Dec 31, 2013 | $96.00K | -48.1% |
| Q3 FY2013 | Sep 30, 2013 | $133.00K | -28.5% |
| Q2 FY2013 | Jun 30, 2013 | $107.00K | -58.2% |
| Q1 FY2013 | Mar 31, 2013 | $228.00K | -27.2% |
| Q4 FY2012 | Dec 31, 2012 | $185.00K | -26.9% |
| Q3 FY2012 | Sep 30, 2012 | $186.00K | -53.6% |
| Q2 FY2012 | Jun 30, 2012 | $256.00K | -21.7% |
| Q1 FY2012 | Mar 31, 2012 | $313.00K | -6.3% |
| Q4 FY2011 | Dec 31, 2011 | $253.00K | -35.9% |
| Q3 FY2011 | Sep 30, 2011 | $401.00K | -3.8% |
| Q2 FY2011 | Jun 30, 2011 | $327.00K | +97.0% |
| Q1 FY2011 | Mar 31, 2011 | $334.00K | – |
| Q4 FY2010 | Dec 31, 2010 | $395.00K | – |
| Q3 FY2010 | Sep 30, 2010 | $417.00K | – |
| Q2 FY2010 | Jun 30, 2010 | $166.00K | – |
See a number that looks wrong?